Publication | Closed Access
Pharmacokinetics and toxicity of docetaxel: Role of CYP3A, MDR1, and GST polymorphisms
138
Citations
47
References
2006
Year
Patients carrying the CYP3A*1B allele may have enhanced docetaxel clearance and may be underexposed, whereas those carrying GSTP1*A/*B and 3435TT genotypes may have excessive hematologic toxicity. Further studies are warranted to determine the usefulness of genotyping before docetaxel treatment.
| Year | Citations | |
|---|---|---|
2004 | 5.7K | |
2000 | 2.4K | |
2001 | 2.2K | |
1991 | 956 | |
2001 | 749 | |
1997 | 742 | |
1997 | 721 | |
1998 | 678 | |
2002 | 661 | |
2003 | 654 |
Page 1
Page 1